Riskpilot← Back to searchSign inGet full accessLIMWRIC AS
ASActiveOrg 983987443Leiv Eirikssons Gate 8, 2004 LillestrømTranslation and interpretation activities · NACE 7430Est. 20021 employeeswww.limwric.no
Revenue 2024
NOK 208K
-33% vs 2023
EBITDA margin
-28.7%
-112% vs 2023
Equity ratio
40.1%
Financial strength
Net profit 2024
NOK -60K
-112% vs 2023
| Revenue | NOK 208K | -33% |
| EBITDA | NOK -60K | -112% |
| Net profit | NOK -60K | -112% |
| Total assets | NOK 36K | -69% |
| Equity | NOK 14K | -81% |
| Employees | 1 | — |
Legal name
LIMWRIC AS
Org number
983987443
Legal form
Aksjeselskap
NACE code
7430 · Translation and interpretation activities
Founded
7. januar 2002
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Konsulenttjenester for legemiddelindustrien og andre medisinske miljøer som omfatte følgende skriving av dokumentasjon av kliniske forsøk (protokoller, rapporter, publikasjoner, presentasjoner, pasientinformasjon, søknader til etikk-komiteer og myndigheter etc.) for legemiddelindustri primært, men også for andre medisinske miljøer - f.eks. For doktorgradstudenter eller hovedfagsstudenter. Ledelse av kliniske forsøk, dvs. Samkjøring av sykehuspersonell, monitor, statistikker, datahåndteringspersonell og skrivevirksomhet. Foredrag og kursvirksomhet overfor målgrupper som nevnt over.
Address
Leiv Eirikssons Gate 8, 2004 Lillestrøm
Website
www.limwric.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 589 | 590 | 505 | 311 | 208 |
| Staff expenses | −284 | −501 | −392 | −225 | −149 |
| EBITDA | 49 | −32 | −2 | −28 | −60 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 49 | −32 | −2 | −28 | −60 |
| Net financials | 2 | 0 | 0 | 0 | 0 |
| Profit before tax | 51 | −32 | −2 | −28 | −60 |
| Tax | 11 | −0 | −0 | −0 | −0 |
| Net profit | 40 | −32 | −2 | −28 | −60 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 200 | 203 | 193 | 117 | 36 |
| Equity | 136 | 104 | 102 | 74 | 14 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 64 | 99 | 91 | 42 | 21 |
| Total debt | 64 | 99 | 91 | 42 | 21 |
EBITDA margin
-28.7%
This company
15.8%
Market median
-282% vs market
20202024
Equity ratio
40.1%
This company
38.2%
Market median
+5% vs market
20202024
Return on equity
-415.5%
This company
18.4%
Market median
-2358% vs market
20202024
Net profit margin
-28.7%
This company
8.1%
Market median
-454% vs market
20202024
Asset turnover
5.81×
This company
1.12×
Market median
+419% vs market
20202024
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AS Deputy Member | Deputy Member | 2002 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2002 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LIMWRIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Skinningsrud | Deputy Member | 0 companies |
| Kari Skinningsrud | Chairman | 0 companies |